[go: up one dir, main page]

PT3724336T - Improved compound for treatment of heart failure - Google Patents

Improved compound for treatment of heart failure

Info

Publication number
PT3724336T
PT3724336T PT188338495T PT18833849T PT3724336T PT 3724336 T PT3724336 T PT 3724336T PT 188338495 T PT188338495 T PT 188338495T PT 18833849 T PT18833849 T PT 18833849T PT 3724336 T PT3724336 T PT 3724336T
Authority
PT
Portugal
Prior art keywords
treatment
heart failure
improved compound
compound
improved
Prior art date
Application number
PT188338495T
Other languages
Portuguese (pt)
Original Assignee
Medizinische Hochschule Hannover
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinische Hochschule Hannover filed Critical Medizinische Hochschule Hannover
Publication of PT3724336T publication Critical patent/PT3724336T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/113Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/323Chemical structure of the sugar modified ring structure
    • C12N2310/3231Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/34Spatial arrangement of the modifications
    • C12N2310/346Spatial arrangement of the modifications having a combination of backbone and sugar modifications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
PT188338495T 2017-12-15 2018-12-14 Improved compound for treatment of heart failure PT3724336T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17207738 2017-12-15

Publications (1)

Publication Number Publication Date
PT3724336T true PT3724336T (en) 2022-04-06

Family

ID=60673706

Family Applications (1)

Application Number Title Priority Date Filing Date
PT188338495T PT3724336T (en) 2017-12-15 2018-12-14 Improved compound for treatment of heart failure

Country Status (1)

Country Link
PT (1) PT3724336T (en)

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
EP3261713A4 (en) Blood pump for treatment of bradycardia
IL270752B (en) Pyrrolopyridine-aniline compounds for treatment of dermal disorders
GB201804514D0 (en) Treatment of pyroptosis
EP3169259A4 (en) Cardiac cryolipolysis for the treatment of cardiac arrhythmia
IL257355B (en) Selection of patients for combination therapy
IL259297A (en) Heterocyclic compounds for the treatment of disease
GB2564801B (en) Implantable scaffolds for treatment of sinusitis
SG11201704781XA (en) Prevention of progressive heart failure
IL250662A0 (en) Tissue protecting devices for treatment of congestive heart failure and other conditions
IL280243A (en) 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure
EP3256137A4 (en) Method of treating heart failure
GB201804515D0 (en) Treatment of necroptosis
IL275273A (en) Improved compound for treatment of heart failure
EP3259346A4 (en) P63 inactivation for the treatment of heart failure
GB201907305D0 (en) Treatment of conditions
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
ES3049333T3 (en) Compounds for the treatment of respiratory diseases
EP3503965B8 (en) Treatment of cardiac dysfunction
SG11201705889VA (en) Prevention or Treatment of Uratic or Gouty Diseases
EP3601565A4 (en) Mir-92 inhibitors for treatment of heart failure
GB201514302D0 (en) Lactobacilli for treating cardiac dysfunction
PT3724336T (en) Improved compound for treatment of heart failure
PL3710043T3 (en) Fgf10 for the treatment of heart diseases
HK40070316B (en) Heterocyclic compounds for the treatment of disease